Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming Hou

Showing results (691-700 of 713) with videos related to

Pageof 72
Sort By:
Neurology. Genetics|June 14, 2019
Loss-of-function mutations in Lysyl-tRNA synthetase cause various leukoencephalopathy phenotypesChong Sun, Jie Song, Yanjun Jiang, et al.
Annals of Hematology|December 19, 2023
Efficacy and safety of generic pomalidomide plus low-dose dexamethasone in relapsed or refractory multiple myeloma: a multicenter, open-label, single-arm trialHuixing Zhou, Yafei Wang, Jiao Chen, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 9, 2010
[Overview of chronic myelogenous leukemia and its current diagnosis and treatment patterns in 15 hospitals in China.]Jian-Xiang Wang, Xiao-Jun Huang, De-Pei Wu, et al.
Journal of Thrombosis and Haemostasis : JTH|November 25, 2021
Dose tapering to withdrawal stage and long-term efficacy and safety of hetrombopag for the treatment of immune thrombocytopenia: Results from an open-label extension studyHeng Mei, Xiaofan Liu, Yan Li, et al.
Journal of Hematology & Oncology|February 26, 2021
A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopeniaHeng Mei, Xiaofan Liu, Yan Li, et al.
Blood Advances|November 24, 2020
A risk score for predicting hospitalization for community-acquired pneumonia in ITP using nationally representative dataYe-Jun Wu, Ming Hou, Hui-Xin Liu, et al.
The Lancet. Haematology|May 26, 2019
Anthracycline dose optimisation in patients with diffuse large B-cell lymphoma: a multicentre, phase 3, randomised, controlled trialPeng-Peng Xu, Di Fu, Jian-Yong Li, et al.
Leukemia Research|April 1, 2015
Standardized fluorescence in situ hybridization testing based on an appropriate panel of probes more effectively identifies common cytogenetic abnormalities in myelodysplastic syndromes than conventional cytogenetic analysis: a multicenter prospective study of 2302 patients in ChinaYue-Yun Lai, Xiao-Jun Huang, Juan Li, et al.
Frontiers in Oncology|November 22, 2021
A Multi-Center, Real-World Study of Chidamide for Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas in ChinaWeiping Liu, Donglu Zhao, Ting Liu, et al.
Cancer Cell|March 19, 2020
Genomic and Transcriptomic Characterization of Natural Killer T Cell LymphomaJie Xiong, Bo-Wen Cui, Nan Wang, et al.
Pageof 72

Showing results (691-700 of 713) with videos related to

Sort By:
Pageof 72
Neurology. Genetics|June 14, 2019
Loss-of-function mutations in Lysyl-tRNA synthetase cause various leukoencephalopathy phenotypesChong Sun, Jie Song, Yanjun Jiang, et al.
Annals of Hematology|December 19, 2023
Efficacy and safety of generic pomalidomide plus low-dose dexamethasone in relapsed or refractory multiple myeloma: a multicenter, open-label, single-arm trialHuixing Zhou, Yafei Wang, Jiao Chen, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 9, 2010
[Overview of chronic myelogenous leukemia and its current diagnosis and treatment patterns in 15 hospitals in China.]Jian-Xiang Wang, Xiao-Jun Huang, De-Pei Wu, et al.
Journal of Thrombosis and Haemostasis : JTH|November 25, 2021
Dose tapering to withdrawal stage and long-term efficacy and safety of hetrombopag for the treatment of immune thrombocytopenia: Results from an open-label extension studyHeng Mei, Xiaofan Liu, Yan Li, et al.
Journal of Hematology & Oncology|February 26, 2021
A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopeniaHeng Mei, Xiaofan Liu, Yan Li, et al.
Blood Advances|November 24, 2020
A risk score for predicting hospitalization for community-acquired pneumonia in ITP using nationally representative dataYe-Jun Wu, Ming Hou, Hui-Xin Liu, et al.
The Lancet. Haematology|May 26, 2019
Anthracycline dose optimisation in patients with diffuse large B-cell lymphoma: a multicentre, phase 3, randomised, controlled trialPeng-Peng Xu, Di Fu, Jian-Yong Li, et al.
Leukemia Research|April 1, 2015
Standardized fluorescence in situ hybridization testing based on an appropriate panel of probes more effectively identifies common cytogenetic abnormalities in myelodysplastic syndromes than conventional cytogenetic analysis: a multicenter prospective study of 2302 patients in ChinaYue-Yun Lai, Xiao-Jun Huang, Juan Li, et al.
Frontiers in Oncology|November 22, 2021
A Multi-Center, Real-World Study of Chidamide for Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas in ChinaWeiping Liu, Donglu Zhao, Ting Liu, et al.
Cancer Cell|March 19, 2020
Genomic and Transcriptomic Characterization of Natural Killer T Cell LymphomaJie Xiong, Bo-Wen Cui, Nan Wang, et al.
Pageof 72